T14, A Non-modulating 150-Kd T Cell Surface Antigen

  • Hannes Stockinger
  • Otto Majdic
  • Kristof Liszka
  • Ursula Köller
  • Wolfgang Holter
  • Christian Peschel
  • Peter Bettelheim
  • Heinz Gisslinger
  • Walter Knapp


Monoclonal antibodies to human T lymphocyte surface structures have essentially contributed to a better understanding of cellular mechanisms and interactions involved in the generation of human T cell responses (1). Such antibodies have also proven useful in recent years in the diagnosis of autoimmune, immunodeficiency, and malignant diseases (2). Not surprisingly, monoclonal antibodies to human T lymphocytes are also increasingly used in the treatment of malignant diseases and for selective T cell elimination in bone marrow (3–5) and kidney transplantation (6–8).


Cell Surface Antigen Cell Antibody Sezary Syndrome Acute Monocytic Leukemia Rabbit Complement 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Reinherz, E.L., and S.F. Schlossman. 1980. The differentiation and function of human T lymphocytes. Cell 19: 821.PubMedCrossRefGoogle Scholar
  2. 2.
    Schlossman, S.F., and E.L. Reinherz. 1984. Human T-cell subsets in health and disease. Springer Semin. Immunopathol. 7: 9.PubMedCrossRefGoogle Scholar
  3. 3.
    Reinherz, E.L., R. Geha, J.M. Rappeport, M. Wilson, A.C. Penta, R.E. Hussey, K.A. Fitzgerald, J.F. Daley, H. Levine, F.S. Rosen, and S.F. Schlossman. 1982. Reconstitution after transplantation with T-lymphocytedepleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency. Proc. Natl. Acad. Sci. U.S.A. 79: 6047.PubMedCrossRefGoogle Scholar
  4. 4.
    Blacklock, H.A., H.G. Prentice, and M.J.M.L. Gilmore. 1983. Attempts at T-cell depletion using OKT3 and rabbit complement to prevent a GvHD in allogeneic BMT. Exp. Hematol. 11 (suppl. 13): 37.Google Scholar
  5. 5.
    Prentice, H.G., G. Janossy, L. Price-Jones, L.K. Trejdosiewicz, D. Panjwani, S. Graphakos, K. Ivory, H.A. Blacklock, M.J.M.L. Gilmore, N. Tidman, D.B.L. Skeggs, S. Ball, J. Patterson, and A.V. Hoffbrand. 1984. Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukemic marrow transplant recipients. Lancet 1984 (1): 472.CrossRefGoogle Scholar
  6. 6.
    Cosimi, A.B., R.C. Burton, R.B. Colvin, G. Goldstein, F.L. Delmonico, M.P. LaQuaglia, N. Toilkoff-Rubin, R.H. Rubin, J.T. Herrin, and P.S. Russell. 1981. Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. Transplantation 32: 535.PubMedCrossRefGoogle Scholar
  7. 7.
    Cosimi, A.B., R.B. Colvin, F.L. Delmonico, and P.S. Russell. 1981. Use of monoclonal antibodies to T cell subsets for immunologic monitoring and treatment in recipients of renal allografts. New England J. Med. 305: 308.CrossRefGoogle Scholar
  8. 8.
    Carpenter, C.B., and T.B. Strom. 1984. Immunosuppressive therapy for renal transplantation. Springer Semin. Immunopathol. 7: 43.PubMedCrossRefGoogle Scholar
  9. 9.
    Miller, R.A., D.G. Maloney, J. McKillop, and R. Levy. 1981. In vivo effects of a murine hybridoma monoclonal antibody in a patient with T cell leukemia. Blood 58: 78.Google Scholar
  10. 10.
    Ritz, J., J.M. Pesandro, S.E. Sallan, L.A. Clavell, J. Notis-McConorty, P. Rosenthal, and S. Schlossman. 1981. Serotherapy of acute lymphoblastic leukemia with monoclonal antibody. Blood 58: 141.PubMedGoogle Scholar
  11. 11.
    Miller, R.A., and R. Levy. 1981. Response of cutaneous T cell lymphoma to therapy with hybridoma monoclonal antibody. Lancet 1981 (2): 226.CrossRefGoogle Scholar
  12. 12.
    Miller, R.A., A.R. Oseroff, R.T. Stratte, and R. Levy. 1983. Monoclonal antibody therapeutic trials in seven patients with T-cell lymphoma. Blood 62: 988.PubMedGoogle Scholar
  13. 13.
    Köhler, G., and C. Milstein. 1975. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495.PubMedCrossRefGoogle Scholar
  14. 14.
    Majdic, O., K. Liszka, D. Lutz, and W. Knapp. 1981. Myeloid differentiation antigen defined by a monoclonal antibody. Blood 58: 1127.PubMedGoogle Scholar
  15. 15.
    Collins, S.J., R.C. Gallo, and R.E. Gallagher. 1977. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 270: 347.PubMedCrossRefGoogle Scholar
  16. 16.
    Koeffler, H.P., and D.W. Golde. 1978. Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity. Science 200: 1153.PubMedCrossRefGoogle Scholar
  17. 17.
    Sundström, C., and K. Nilsson. 1976. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer 17: 565.PubMedCrossRefGoogle Scholar
  18. 18.
    Tsuchiya, S., Y. Yamaguchi, Y. Kobayashi, T. Konno, and K. Tada. 1980. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer 26: 171.PubMedCrossRefGoogle Scholar
  19. 19.
    Lozzio, C.B., and B.B. Lozzio. 1975. Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood 45: 321.PubMedGoogle Scholar
  20. 20.
    Martin, P., and T. Papayannopoulou. 1982. HEL cells: A new human erythroleukemia cell line with spontaneous and induced globin expression. Science 216: 1233.PubMedCrossRefGoogle Scholar
  21. 21.
    Rosenfeld, C., A. Goutner, A.M. Venuat, C. Choquet, J.L. Pico, J.F. Dore, A. Liabeuf, A. Durandy, C. Desgrange, and G. De-The. 1977. An effective human leukaemic cell line, Reh. Eur. J. Cancer 13: 377.PubMedGoogle Scholar
  22. 22.
    Pulvertaft, R.J.V. 1964. Cytology of Burkitt’s tumour. Lancet 1964 (1): 238.CrossRefGoogle Scholar
  23. 23.
    Minowada, J., T. Olinuma, and G.E. Moore. 1973. Rosette-forming human lymphoid cell line. Establishment and evidence for origin of thymus derived lymphocytes. J. Natl. Cancer Inst. 49: 891.Google Scholar
  24. 24.
    Schneider, U., H.U. Schwenk, and G. Bornkamm 1977. Characterization of EBV-genome negative “null” and “T”-cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int. J. Cancer 19: 621.PubMedCrossRefGoogle Scholar
  25. 25.
    Konwalinka, G., Ch. Peschel, D. Geissler, B. Tomaschek, J. Boyd, R. Odavic, and H. Braunsteiner. 1983. Myelopoiesis of human bone marrow cells in a micro-agar culture system: comparison of two sources of colony stimulating activity (CSA). Int. J. Cell Cloning 1: 401.PubMedCrossRefGoogle Scholar
  26. 26.
    Konwalinka, G., Ch. Peschel, J. Boyd, D. Geissler, M. Ogriseg, R. Odavic, and H. Braunsteiner. 1984. A miniaturized agar culture system for cloning human erythropoietic progenitor cells. Exp. Haemat. 12: 75.Google Scholar
  27. 27.
    Geissler, D., G. Konwalinka, Ch. Peschel, J. Boyd, R. Odavic, and H. Braunsteiner. 1983. Clonal growth of human megakaryocytic progenitor cells in a micro agar culture system: simultaneous proliferation of megakaryocytic, granulocytic and erythroid progenitor cells (CFU-M, CFU-C, BFU-E) and T-lymphocytic colonies (CFU-TL). Int. J. Cell Cloning 1: 377.PubMedCrossRefGoogle Scholar
  28. 28.
    Meuer, S.C., K.A. Fitzgerald, R.E. Hussey, J.C. Hodgolon, S.F. Schlossmann, and E.L. Reinherz. 1983. Clonotypic structures involved in antigen-specific human T cell function. J. Exp. Med. 157: 705.PubMedCrossRefGoogle Scholar
  29. 29.
    Reinherz, E.L., S. Meuer, K.A. Fitzgerald, R.E. Hussey, H. Levine, and S.F. Schlossmann. 1982. Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complex. Cell 30: 735.PubMedCrossRefGoogle Scholar
  30. 30.
    LeBien, T.W., D.R. Boue, J. Bradley, and J.M. Kersey. 1982. Antibody affinity may influence antigenic modulation of the common acute lymphoblastic leukemia antigen in vitro. J. Immunol. 129: 2287.Google Scholar
  31. 31.
    Reinherz, E.L., P.C. Kung, G. Goldstein, and S.F. Schlossman. 1979. A monoclonal antibody with selective reactivity with functionally mature thymocytes and all peripheral human T cells. J. Immunol. 123: 1312.PubMedGoogle Scholar
  32. 32.
    Van Wauwe, J., J. De Mey, and J. Goossens. 1980. OKT3: a monoclonal antihuman T lymphocyte antibody with potent mitogenic properties. J. Immunol. 124: 2708.PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1986

Authors and Affiliations

  • Hannes Stockinger
  • Otto Majdic
  • Kristof Liszka
  • Ursula Köller
  • Wolfgang Holter
  • Christian Peschel
  • Peter Bettelheim
  • Heinz Gisslinger
  • Walter Knapp

There are no affiliations available

Personalised recommendations